You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic GvHD (cGvHD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD, Chronic Trial in China (BN101)

Recruiting
  • GVHD, Chronic
  • Beijing, China
  • +7 more
Apr 24, 2022

Pediatric cGVHD Symptom Scale

Recruiting
  • Graft vs Host Disease
    • Aurora, Colorado
    • +11 more
    Jan 27, 2023

    Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

    Approved for marketing
    • Graft-versus-host Disease (GVHD)
    • (no location specified)
    Jan 26, 2023

    cGVHD Trial in Guanzhou (Belimumab (Benlysta))

    Withdrawn
    • cGVHD
    • Belimumab (Benlysta)
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Jan 16, 2023

    Patients at Risk for Chronic Graft-Versus-Host Disease

    Not yet recruiting
    • cGVHD
    • Non-Interventional
    • (no location specified)
    Jun 16, 2023

    Chronic GVHD Trial in Duarte (biological, procedure, other)

    Active, not recruiting
    • Chronic Graft Versus Host Disease
    • Aldesleukin
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Microbiota Composition With cGVHD After Allo-HSCT

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • +3 more
    • blood sample
    • stool sample
    • Hangzhou, Zhejiang, China
    • +9 more
    Jul 31, 2022

    GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

    Terminated
    Has Results
    • Graft Versus Host Disease
    • +2 more
    • Ruxolitinib 1.5% cream
    • vehicle cream
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 21, 2022

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte

    Recruiting
    • Acute Leukemia
    • +2 more
    • Darlinghurst, New South Wales, Australia
    • +8 more
    Aug 30, 2021

    Hematological Malignancies Trial in Durham (fostamatinib)

    Active, not recruiting
    • Hematological Malignancies
    • Durham, North Carolina
      Duke University of Medicine
    Jul 14, 2022

    Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Duarte, California
      City of Hope Site Number : 8400001
    Nov 23, 2023

    Chronic GVHD Trial in Shanghai (SHR0302, Prednisone)

    Recruiting
    • Chronic GVHD
    • Shanghai, Shanghai, China
    • +1 more
    Aug 4, 2022

    GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

    Active, not recruiting
    • GVHD, Chronic
    • Hematological Malignancy
    • Lee Symptom Scala
    • Copenhagen, Denmark
      Rigshospitalet
    Jul 14, 2022

    Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Steroid Refractory Graft Versus Host Disease
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Chronic GVHD Response Measures Validation

    Active, not recruiting
    • Graft vs Host Disease
      • Seattle, Washington
        Fred Hutchinson Cancer Research Center
      Feb 28, 2022

      Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

      Active, not recruiting
      • Hematologic Malignancy
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Jan 31, 2023

      Graft Vs Host Disease Trial in Atlanta (Rituximab, Ibrutinib)

      Recruiting
      • Graft Vs Host Disease
      • Atlanta, Georgia
        Northside Hospital
      Oct 19, 2022

      Chronic GVHD Trial (Belumosudil)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • (no location specified)
      Jan 5, 2023

      Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

      Not yet recruiting
      • Chronic Graft-versus-Host-Disease
      • +4 more
        • (no location specified)
        Jan 11, 2023

        Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

        Active, not recruiting
        • Chronic Graft-versus-host-disease
        • Salt Lake City, Utah
          Huntsman Cancer Institute at University of Utah
        Jan 30, 2023

        Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

        Recruiting
        • Chronic Graft vs Host Disease
          • Bucheon-Si, Korea, Republic of
          • +9 more
          Jan 27, 2023

          Testing for Chronic Graft Versus Host Disease, CATCH Study

          Recruiting
          • Hematopoietic and Lymphoid Cell Neoplasm
          • Biospecimen Collection
          • +6 more
          • Gainesville, Florida
          • +6 more
          Jan 25, 2023

          Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

          Recruiting
          • Chronic Graft-versus-Host-Disease
          • +4 more
            • San Francisco, California
            • +15 more
            Jun 17, 2022

            Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

            Recruiting
            • Chronic Graft vs Host Disease
            • Regulatory T-cell enriched infusion
            • Sevilla, Spain
              José Antonio Pérez Simón
            May 20, 2022